Abstract
Background
Patients with obesity are predisposed to a reduction in end-expiratory lung volume (EELV) and atelectasis after anaesthesia. High flow nasal oxygen (HFNO) may increase EELV, reducing the likelihood of postoperative pulmonary complications (PPC). We conducted a pilot randomised controlled trial (RCT) of conventional oxygen therapy versus HFNO after bariatric surgery. The aim was to investigate the feasibility of using electrical impedance tomography (EIT) as a means of assessing respiratory mechanics and to inform the design of a definitive RCT.
Methods
We performed a single-centre, parallel-group, pilot RCT. Adult patients with obesity undergoing elective bariatric surgery were eligible for inclusion. We excluded patients with a known contraindication to HFNO or with chronic lung disease.
Results
Fifty patients were randomised in equal proportions. One patient crossed over from conventional O2 to HFNO. Delta EELI was higher at 1 hour in patients receiving HFNO (mean difference = 831 Au (95% CI − 1636–3298), p = 0.5). Continuous EIT beyond 1 hour was poorly tolerated. At 6 hours, there were no differences in PaO2/FiO2 ratio or PaCO2. Only one patient developed a PPC (in the HFNO group) by 6 weeks.
Conclusions
These data suggest that a large-scale RCT of HFNO after bariatric surgery in an ‘all-comers’ population is likely infeasible. While EIT was an effective means of assessing respiratory mechanics, it was impractical over time. Similarly, the infrequency of PPC precludes its use as a primary outcome. Future studies should focus on identifying patients at the greatest risk of PPC.
Graphical abstract
Similar content being viewed by others
References
Ng M, Fleming T, Robinson M, et al. Global, regional, and national prevalence of overweight and obesity in children and adults during 1980–2013: a systematic analysis for the Global Burden of Disease Study 2013. Lancet (London, England). 2014;384(9945):766–81.
Angrisani L, Santonicola A, Iovino P, et al. IFSO Worldwide Survey 2016: primary, endoluminal, and revisional procedures. Obes Surg. 2018;28(12):3783–94.
Welbourn R, Hollyman M, Kinsman R, et al. Bariatric surgery worldwide: baseline demographic description and one-year outcomes from the fourth IFSO Global Registry Report 2018. Obes Surg. 2019;29(3):782–95.
Bamgbade OA, Rutter TW, Nafiu OO, et al. Postoperative complications in obese and nonobese patients. World J Surg. 2007;31(3):556–60 (discussion 561).
Littleton SW, Tulaimat A. The effects of obesity on lung volumes and oxygenation. Respir Med. 2017;124:15–20.
Oppenheimer BW, Berger KI, Segal LN, et al. Airway dysfunction in obesity: response to voluntary restoration of end expiratory lung volume. PloS One. 2014;9(2):e88015.
Parameswaran K, Todd DC, Soth M. Altered respiratory physiology in obesity. Can Respir J. 2006;13(4):203–10.
Rivas E, Arismendi E, Agustí A, et al. Ventilation/perfusion distribution abnormalities in morbidly obese subjects before and after bariatric surgery. Chest. 2015;147(4):1127–34.
Baltieri L, Peixoto-Souza FS, Rasera-Junior I, et al. Analysis of the prevalence of atelectasis in patients undergoing bariatric surgery. Rev Bras Anestesiol. 2016;66(6):577–82.
Benoist S, Panis Y, Alves A, et al. Impact of obesity on surgical outcomes after colorectal resection. Am J Surg. 2000;179(4):275–81.
Merkow RP, Bilimoria KY, McCarter MD, et al. Effect of body mass index on short-term outcomes after colectomy for cancer. J Am Coll Surg. 2009;208(1):53–61.
Mullen JT, Davenport DL, Hutter MM, et al. Impact of body mass index on perioperative outcomes in patients undergoing major intra-abdominal cancer surgery. Ann Surg Oncol. 2008;15(8):2164–72.
Ashraf-Kashani N, Kumar R. High-flow nasal oxygen therapy. BJA Education. 2017;17(2):57–62.
Corley A, Caruana LR, Barnett AG, et al. Oxygen delivery through high-flow nasal cannulae increase end-expiratory lung volume and reduce respiratory rate in post-cardiac surgical patients. Br J Anaesth. 2011;107(6):998–1004.
Thabane L, Hopewell S, Lancaster GA, et al. Methods and processes for development of a CONSORT extension for reporting pilot randomized controlled trials. Pilot Feas Stud. 2016;2(1):25.
Fulton R, Millar JE, Merza M, et al. High flow nasal oxygen after bariatric surgery (OXYBAR), prophylactic post-operative high flow nasal oxygen versus conventional oxygen therapy in obese patients undergoing bariatric surgery: study protocol for a randomised controlled pilot trial. Trials. 2018;19(1):402.
Mauri T, Turrini C, Eronia N, et al. Physiologic effects of high-flow nasal cannula in acute hypoxemic respiratory failure. Am J Respir Crit Care Med. 2017;195(9):1207–15.
Riera J, Pérez P, Cortés J, et al. Effect of high-flow nasal cannula and body position on end-expiratory lung volume: a cohort study using electrical impedance tomography. Respir Care. 2013;58(4):589–96.
Borg G. Borg’s perceived exertion and pain scales. Champaign, IL: Human Kinetics, 1998.
Zhang R, He H, Yun L, et al. Effect of postextubation high-flow nasal cannula therapy on lung recruitment and overdistension in high-risk patient. Crit Care. 2020;24(1):82.
Yu Y, Qian X, Liu C, et al. Effect of high-flow nasal cannula versus conventional oxygen therapy for patients with thoracoscopic lobectomy after extubation. Can Respir J. 2017;2017:7894631.
BodurYildirim F, Öcal S, ErsoyOrtac E, et al. High flow nasal oxygen therapy usage in the adult intensive care units in Turkey: multi-center, prospective study. Eur Res J. 2019;54(suppl 63):PA4020.
Lu Z, Chang W, Meng S-S, et al. Effect of high-flow nasal cannula oxygen therapy compared with conventional oxygen therapy in postoperative patients: a systematic review and meta-analysis. BMJ Open. 2019;9(8):e027523.
Kelkar KV. Post-operative pulmonary complications after non-cardiothoracic surgery. Indian J Anaesth. 2015;59(9):599–605.
Gupta PK, Gupta H, Kaushik M, et al. Predictors of pulmonary complications after bariatric surgery. Surg Obes Relat Dis. 2012;8(5):574–81.
Funding
The study was funded by Wesley Medical Research (Australia).
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of Interest
The study received grant funding from Wesley Medical Research (Australia). The corresponding author has received travel and research support from Fisher & Paykel Pty Ltd. Rachel Fulton has no conflict of interest. Jonathan Millar has received honoraria from Fisher & Paykel Pty Ltd for an educational activity. Megan Merza and Helen Johnston have no conflict of interest. Amanda Corley has received honoraria from Fisher & Paykel Pty Ltd for an educational activity. Daniel Faulke, Ivan Rapchuk, Joe Tarpey, Jonathon Fanning, Philip Lockie, and Shirley Lockie have no conflict of interest. John Fraser has received honoraria from Fisher & Paykel Ltd. For educational activity and research support unrelated to this study. Fisher & Paykel Pty Ltd were not involved in the conception, design, or analysis of this study.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Key Points
• HFNO failed to produce a significant increase in EELI at 60 min.
• The use of HFNO was not associated with improvements in PaO2/FiO2 ratio, dyspnoea, length of stay, or the incidence of postoperative pulmonary complications. However, the incidence of PPC was low.
• The use of HFNO was associated with higher pain scores at 6 hours.
• Based on these data, a large-scale RCT of HFNO after bariatric surgery in an ‘all-comers’ population is likely infeasible.
Rights and permissions
About this article
Cite this article
Fulton, R., Millar, J.E., Merza, M. et al. Prophylactic Postoperative High Flow Nasal Oxygen Versus Conventional Oxygen Therapy in Obese Patients Undergoing Bariatric Surgery (OXYBAR Study): a Pilot Randomised Controlled Trial. OBES SURG 31, 4799–4807 (2021). https://doi.org/10.1007/s11695-021-05644-y
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11695-021-05644-y